Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for medical attention.

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...